Literature DB >> 19153732

What role for recombinant human TSH in the treatment of metastatic thyroid cancer?

Paolo Zanotti-Fregonara, Elif Hindié, Marie Elisabeth Toubert, Domenico Rubello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19153732     DOI： 10.1007/s00259-008-1046-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  20 in total

1.  Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

Authors:  P W Ladenson; L E Braverman; E L Mazzaferri; F Brucker-Davis; D S Cooper; J R Garber; F E Wondisford; T F Davies; L J DeGroot; G H Daniels; D S Ross; B D Weintraub
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

2.  Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.

Authors:  Christian Pötzi; Abbas Moameni; Georgios Karanikas; Josef Preitfellner; Alexander Becherer; Christian Pirich; Robert Dudczak
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

3.  Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin.

Authors:  R J Robbins; R M Tuttle; M Sonenberg; A Shaha; R Sharaf; H Robbins; M Fleisher; S M Larson
Journal:  Thyroid       Date:  2001-09       Impact factor: 6.568

Review 4.  rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

Authors:  Markus Luster; Francesco Lippi; Barbara Jarzab; Petros Perros; Michael Lassmann; Christoph Reiners; Furio Pacini
Journal:  Endocr Relat Cancer       Date:  2005-03       Impact factor: 5.678

5.  Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.

Authors:  V Lazar; J M Bidart; B Caillou; C Mahé; L Lacroix; S Filetti; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

6.  Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration.

Authors:  M Braga; M D Ringel; D S Cooper
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

7.  Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen.

Authors:  I Borget; H Remy; J Chevalier; M Ricard; M Allyn; M Schlumberger; G De Pouvourville
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-02       Impact factor: 9.236

8.  Two cases of thyroid carcinoma that were not stimulated by recombinant human thyrotropin.

Authors:  A A Driedger; N Kotowycz
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

9.  Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.

Authors:  C F A Eustatia-Rutten; J W A Smit; J A Romijn; E P M van der Kleij-Corssmit; A M Pereira; M P Stokkel; J Kievit
Journal:  Clin Endocrinol (Oxf)       Date:  2004-07       Impact factor: 3.478

10.  Second primary malignancies in thyroid cancer patients.

Authors:  C Rubino; F de Vathaire; M E Dottorini; P Hall; C Schvartz; J E Couette; M G Dondon; M T Abbas; C Langlois; M Schlumberger
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640
View more
  1 in total

1.  Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.

Authors:  Tianpeng Hu; Zhaowei Meng; Guizhi Zhang; Qiang Jia; Jian Tan; Wei Zheng; Renfei Wang; Xue Li; Na Liu; Pingping Zhou; Arun Upadhyaya
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.